Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.
| Autor: | Kallen AJ; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. AKallen@cdc.gov, Beekmann SE, Limbago B, Lentnek AL, Polgreen PM, Patel J, Srinivasan A |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2011 Nov; Vol. 71 (3), pp. 316-9. Date of Electronic Publication: 2011 Sep 06. |
| DOI: | 10.1016/j.diagmicrobio.2011.07.013 |
| Abstrakt: | Beta-lactam-resistant Enterobacteriaceae represent an important public health problem; however, questions exist about their prevalence and the impact of recent breakpoint changes on clinical practice. We surveyed infectious disease physicians to better understand these issues. Many reported encountering resistant Enterobacteriaceae; respondents generally favored a more conservative interpretation of antimicrobial susceptibility results. (Published by Elsevier Inc.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect